BNVA 150
Generic Name: ibandronate
Pill imprint BNVA 150 has been identified as Boniva 150 mg.
Boniva is used in the treatment of osteoporosis; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy.
Boniva 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Boniva Images
- Generic Name:
- ibandronate
- Imprint:
-
BNVA
150 - Strength:
- 150 mg
- Color:
- White
- Size:
- 14.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
povidone
microcrystalline cellulose
crospovidone
stearic acid
silicon dioxide
water
hypromelloses
titanium dioxide
magnesium silicate
polyethylene glycol 6000
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Roche Laboratories
- National Drug Code (NDC):
- 00004-0186
| NDC Code | Manufacturer / Repackager |
|---|---|
| 16590-0400 | Stat RX USA LLC (repackager) |
| 54868-5322 | Physicians Total Care Inc (repackager) |
| 35356-0423 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Boniva resources
Search Again
